Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
El Halabi M, Horanieh R, Tamim H, Mukherji D, Jdiaa S, Temraz S, et al. The impact of age on prognosis in patients with gastric cancer: experience in a tertiary care centre. J Gastrointest Oncol. 2020;11:1233–41.
Kim S, Han IH, Lee S, Park D, Lee H, Kim J, et al. The combination of CD300c antibody with PD-1 blockade suppresses tumor growth and metastasis by remodeling the tumor microenvironment in triple-negative breast cancer. Int J Mol Sci. 2025;26:5045.
He Y, Hong Q, Chen S, Zhou J, Qiu S. Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy. Front Immunol. 2025;16:1558091.
Zou Z, Lin H, Li M, Lin B. Tumor-associated macrophage polarization in the inflammatory tumor microenvironment. Front Oncol. 2023;13:1103149.
Xie H, Xi X, Lei T, Liu H, Xia Z. CD8(+) T cell exhaustion in the tumor microenvironment of breast cancer. Front Immunol. 2024;15:1507283.
Kalus I, Rohn S, Puvirajesinghe TM, Guimond SE, Eyckerman-Kölln PJ, Ten Dam G, et al. Sulf1 and Sulf2 differentially modulate heparan sulfate proteoglycan sulfation during postnatal cerebellum development: evidence for neuroprotective and neurite outgrowth promoting functions. PLoS One. 2015;10:e0139853.
Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, et al. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma. Gastroenterology. 2006;130:2130–44.
Lyu Y, Cheng Y, Wang B, Chen L, Zhao S. Sulfatase 1 expression in pancreatic cancer and its correlation with clinicopathological features and postoperative prognosis. Cancer Biomark Sect A Dis Markers. 2018;22:701–7.
Li Y, Feng T, Wang Q, Wu Y, Wang J, Zhang W, et al. High expression of SULF1 is associated with adverse prognosis in breast cancer brain metastasis. Anim models Exp Med. 2025;8:162–70.
He X, Khurana A, Roy D, Kaufmann S, Shridhar V. Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer. Int J Cancer. 2014;135:1783–9.
Fang X, Chen D, Yang X, Cao X, Cheng Q, Liu K, et al. Cancer associated fibroblasts-derived SULF1 promotes gastric cancer metastasis and CDDP resistance through the TGFBR3-mediated TGF-β signaling pathway. Cell Death Discov. 2024;10:111.
Yi J, Ye Z, Xu H, Zhang H, Cao H, Li X, et al. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Phytomed Int J Phytother Phytopharmacol. 2024;135:156137.
Sun K, Xu R, Ma F, Yang N, Li Y, Sun X, et al. scRNA-seq of complex intercellular interaction with an alternative T cell exhaustion trajectory. Nat Commun. 2022;13:4943.
Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther. 2021;6:72.
Biernacki K, Ciupak O, Daśko M, Rachon J, Kozak W, Rak J, et al. Development of sulfamoylated 4-(1-Phenyl-1H-1,2,3-triazol-4-yl)phenol derivatives as potent steroid sulfatase inhibitors for efficient treatment of breast cancer. J Med Chem. 2022;65:5044–56.
Khurana A, Beleford D, He X, Chien J, Shridhar V. Role of heparan sulfatases in ovarian and breast cancer. Am J Cancer Res. 2013;3:34–45.
Lai JP, Thompson JR, Sandhu DS, Roberts LR. Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. Future Oncol (Lond Engl). 2008;4:803–14.
Hur K, Han TS, Jung EJ, Yu J, Lee HJ, Kim WH, et al. Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer. J Pathol. 2012;228:88–98.
Zheng H, Yu S, Zhu C, Guo T, Liu F, Xu Y. HIF1α promotes tumor chemoresistance via recruiting GDF15-producing TAMs in colorectal cancer. Exp Cell Res. 2021;398:112394.
Mukherjee P, Benicky J, Panigrahi A, Ailles L, Goldman R. SULF1 in cancer-associated fibroblasts promotes invasion in head and neck cancer cell lines. Cancer Med. 2026;15:e71540.
Dammeijer F, van Gulijk M, Mulder EE, Lukkes M, Klaase L, van den Bosch T, et al. The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell. 2020;38:685–700.e8.
Yang XP, Liu L, Wang P, Ma SL. Human sulfatase-1 improves the effectiveness of cytosine deaminase suicide gene therapy with 5-fluorocytosine treatment on hepatocellular carcinoma cell line HepG2 in vitro and in vivo. Chin Med J (Engl). 2015;128:1384–90.